CG Oncology Statistics
NASDAQ: CGONHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
79.47-2.43 (-2.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CG Oncology by the numbers
CG Oncology has a market capitalization of $7.10 billion based on 89.32M shares outstanding. With trailing EPS of $-2.76, CG Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.4% above its 50-day average and 17.9% above its 200-day average.
Average daily trading volume is 1.24M shares, or about $98.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CGON valuation vs. peer median
| Metric | CGON | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.10B | $6.49B | +9% |
| Avg. volume | 1.24M | 2.02M | -39% |
Peer median across 8 companies: TWST, IMVT, IBRX, KOD, SRRK, PCVX, KRYS, ADPT.
Valuation
- Market cap
- $7.10B
- Price / sales (latest FY)
- 1,756.97
- EPS (TTM)
- $-2.76
- Shares outstanding
- 89.32M
Price and trading
- Previous close
- 81.90
- Open
- 80.32
- Day range
- 79.23 – 83.12
- 52-week range
- 37.01 – 93.95
- 52-week change
- +87.25%
- Beta
- —
- Volume
- 1.67M
- Average volume
- 1.24M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 7.10B
- Forward Pe
- -26.91
- Eps
- -2.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 93.95
- Week52 Low
- 37.01
- Avg Volume
- 1.24M
- Shares Outstanding
- 89.32M
- Ma50
- 68.85
- Ma200
- 67.40
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -15.41%
- Pct From52w Low
- 114.73%